We investigated the effects of ethinylestradiol dose (50, 30 and 20 μg) and progestogen type
[desogestrel (DSG), gestodene (GSD), levonorgestrel (LNG) and norgestimate (NGM)] in …

An increased risk of venous thrombosis has been demonstrated in women receiving oral
contraceptives (OCs). This risk has been primarily associated with the oestrogen content, but …

In a 6-month, randomized, double-blind study the effects of two combined oral
contraceptives containing 150 μg desogestrel and either 20 or 30 μg ethinylestradiol on …

This is the first double-blind, controlled, randomized study comparing the effect of different
estrogen components in oral contraceptives (OCs) on hemostasis variables. Four groups of …

This study was undertaken to evaluate the impact of progestins as part of low-estrogen
(ethinyl estradiol [EE2]≤ 35 μg) combined oral contraceptives (COCs) on hemostatic …

In a 6-month, randomized, double-blind study the effects of two combined oral
contraceptives containing 150 micrograms desogestrel and either 20 or 30 micrograms …

Oral contraceptives (OCs) are used by millions of women and have proven to be very
effective in contraception. To a large extent as a consequence of the cardiovascular side …

OBJECTIVES: To comparatively evaluate the impact of a balanced one-third dose-reduced
oral contraceptive on hemostatic variables. METHODS: In an open-label, randomized study …

Objective—To explore the extent to which progestogen type and oestrogen and
progestogen dose may modify the effects of combined oral contraceptives (OC) on …

Objective. The scientific debate on oral contraceptives (OCs) and thrombotic diseases
continues unabated. The aim of this survey was to evaluate available scientific data on OCs …